Astrazeneca admits its Covishield vaccine can cause a rare side effect; should you be worried?

AstraZeneca admits rare blood clot risk (TTS) for Covishield vaccine. Expert explains TTS symptoms, causes & who is at risk. While acknowledging the link, doctor assures benefits outweigh risks & urges monitoring for early detection & treatment.

Related Keywords

Jagadishj Hiremath ,Astrazeneca ,Thrombocytopenia Syndrome ,Covishield Vaccine ,Its ,Thrombosis With Thrombocytopenia Syndrome ,Blood Clots ,Platelets ,Side Effects ,Covid 19 Vaccine Safety ,Public Health ,India ,R Jagadishj Hiremath ,